Gene Therapy for Primary Immunodeficiency
Over the past 3 decades, there has been significant progress in refining gene therapy technologies and procedures. Transduction of hematopoietic stem cells ex vivo using lentiviral vectors can now create a highly effective therapeutic product, capable of reconstituting many different immune system d...
Main Authors: | Benjamin C. Houghton, Claire Booth |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/HS9.0000000000000509 |
Similar Items
-
Gene therapy and genome editing for primary immunodeficiency diseases
by: Zhi-Yong Zhang, et al.
Published: (2020-03-01) -
Immunoglobulin replacement therapy for primary immunodeficiencies.
by: Peter, J, et al.
Published: (2014) -
Gene Edited T Cell Therapies for Inborn Errors of Immunity
by: T. A. Fox, et al.
Published: (2022-06-01) -
Primary immunodeficiency
by: McCusker Christine, et al.
Published: (2011-11-01) -
Primary immunodeficiency
by: Christine McCusker, et al.
Published: (2018-09-01)